Contact this trialFirst, we need to learn more about you.
SGLT2 Inhibitor
Dapagliflozin for Cardiovascular Risk After Hypertensive Pregnancies
Recruiting2 awardsPhase 4
Ann Arbor, Michigan
This trial aims to see if giving dapagliflozin to high-risk patients after childbirth can reduce their risk of heart problems. Participants will be split into two groups: one receiving dapagl
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service